Protagonist Therapeutics, Inc. (PTGX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $9.44B, a trailing price-to-earnings ratio of 141.6 and a free-cash-flow yield of 0.6%. Over the most recent reported fiscal year, revenue declined 89.4% and free cash flow per share fell 68.6%.